title: Complement C3a and C5a modulate osteoclast formation and inflammatory response of osteoblasts in synergism with IL-1β.
abstract: There is a tight interaction of the bone and the immune system. However, little is known about the relevance of the complement system, an important part of innate immunity and a crucial trigger for inflammation. The aim of this study was, therefore, to investigate the presence and function of complement in bone cells including osteoblasts, mesenchymal stem cells (MSC), and osteoclasts. qRT-PCR and immunostaining revealed that the central complement receptors C3aR and C5aR, complement C3 and C5, and membrane-bound regulatory proteins CD46, CD55, and CD59 were expressed in human MSC, osteoblasts, and osteoclasts. Furthermore, osteoblasts and particularly osteoclasts were able to activate complement by cleaving C5 to its active form C5a as measured by ELISA. Both C3a and C5a alone were unable to trigger the release of inflammatory cytokines interleukin (IL)-6 and IL-8 from osteoblasts. However, co-stimulation with the pro-inflammatory cytokine IL-1β significantly induced IL-6 and IL-8 expression as well as the expression of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin (OPG) indicating that complement may modulate the inflammatory response of osteoblastic cells in a pro-inflammatory environment as well as osteoblast-osteoclast interaction. While C3a and C5a did not affect osteogenic differentiation, osteoclastogenesis was significantly induced even in the absence of RANKL and macrophage-colony stimulating factor (M-CSF) suggesting that complement could directly regulate osteoclast formation. It can therefore be proposed that complement may enhance the inflammatory response of osteoblasts and increase osteoclast formation, particularly in a pro-inflammatory environment, for example, during bone healing or in inflammatory bone disorders.
authors: Institute of Orthopaedic Research and Biomechanics, Center of Musculoskeletal Research Ulm, University of Ulm, Ulm, Germany. anita.ignatius@uni-ulm.de
authors: Anita
authors: A
authors: Ignatius
authors: Philipp
authors: P
authors: Schoengraf
authors: Ludwika
authors: L
authors: Kreja
authors: Astrid
authors: A
authors: Liedert
authors: Stefan
authors: S
authors: Recknagel
authors: Sebastian
authors: S
authors: Kandert
authors: Rolf E
authors: RE
authors: Brenner
authors: Marion
authors: M
authors: Schneider
authors: John D
authors: JD
authors: Lambris
authors: Markus
authors: M
authors: Huber-Lang
references: J Trauma. 2011 Oct;71(4):952-60
references: 21460748
references: Nature. 2003 May 15;423(6937):337-42
references: 12748652
references: Clin Immunol. 2006 Feb-Mar;118(2-3):127-36
references: 16338172
references: J Cell Biochem. 2007 Dec 1;102(5):1130-9
references: 17955494
references: J Immunol. 1999 Jun 15;162(12):7409-16
references: 10358194
references: Science. 1999 Apr 2;284(5411):143-7
references: 10102814
references: Exp Cell Res. 1996 Sep 15;227(2):208-13
references: 8831558
references: J Immunol. 1987 Oct 15;139(8):2635-40
references: 3116090
references: Biochem Biophys Res Commun. 2006 Apr 21;342(4):1070-6
references: 16513091
references: Endocrinology. 2005 Apr;146(4):1991-8
references: 15618359
references: Nat Rev Immunol. 2009 Oct;9(10):729-40
references: 19730437
references: Nat Rev Immunol. 2007 Apr;7(4):292-304
references: 17380158
references: Cell Tissue Res. 1997 Jun;288(3):557-65
references: 9134868
references: Int Immunopharmacol. 2001 Mar;1(3):445-59
references: 11367529
references: J Invest Surg. 2006 Jul-Aug;19(4):255-65
references: 16835140
references: Biochem Pharmacol. 2010 Dec 15;80(12):1981-91
references: 20599782
references: Blood. 2010 Nov 25;116(22):4456-63
references: 20709903
references: Mol Immunol. 2009 Sep;46(14):2753-66
references: 19477527
references: J Bone Miner Metab. 2009;27(5):519-29
references: 19455385
references: J Immunol. 1978 Jan;120(1):109-15
references: 342601
references: Cell Signal. 2006 Nov;18(11):1897-905
references: 16574378
references: Blood. 2008 Dec 15;112(13):5084-94
references: 18812470
references: J Cell Biochem. 2010 Feb 1;109(2):347-55
references: 19950208
references: Immunol Res. 2007;37(3):161-75
references: 17873401
references: Surgery. 2004 May;135(5):544-54
references: 15118592
references: Curr Top Microbiol Immunol. 2000;251:3-11
references: 11036752
references: Calcif Tissue Int. 1985 Sep;37(5):453-60
references: 2998572
references: Clin Immunol Immunopathol. 1990 Nov;57(2):297-307
references: 2208809
references: Cytotherapy. 2006;8(4):315-7
references: 16923606
references: Methods Mol Med. 2005;107:55-68
references: 15492364
references: Clin Exp Immunol. 2011 Jan;163(1):88-95
references: 21039424
references: J Immunol. 1990 Feb 1;144(3):1062-8
references: 2295813
references: FEBS Lett. 1991 Jul 8;285(1):21-4
references: 2065778
references: Arthritis Res Ther. 2004;6(5):R422-32
references: 15380042
references: Am J Pathol. 2002 Nov;161(5):1849-59
references: 12414531
references: J Immunol. 2001 Oct 1;167(7):3972-9
references: 11564816
references: Cell Tissue Res. 1994 Aug;277(2):239-45
references: 8082118
references: J Mol Histol. 2007 Oct;38(5):341-5
references: 18161075
references: Mol Med. 2011 Mar-Apr;17(3-4):317-29
references: 21046060
references: Tissue Eng Part A. 2010 Apr;16(4):1143-55
references: 19863253
references: Nat Immunol. 2010 Sep;11(9):785-97
references: 20720586
references: Endocrinology. 1993 Jul;133(1):397-404
references: 8319587
references: J Immunol. 2009 Mar 15;182(6):3827-36
references: 19265162
references: J Periodontal Res. 2000 Jun;35(3):137-45
references: 10929868